atai Life Sciences (ATAI) Misses Q4 EPS by 9c

atai Life Sciences (NASDAQ: ATAI) reported Q4 EPS of ($0.24), $0.09 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• ConAgra Brands board member Chirico to step down at annual meeting
• Morgan Stanley Private Credit Fund Caps Redemptions At 5%